These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1895928)

  • 21. Serotype and apx genotype profiles of Actinobacillus pleuropneumoniae field isolates in Korea.
    Min K; Chae C
    Vet Rec; 1999 Aug; 145(9):251-4. PubMed ID: 10504068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.
    Inzana TJ; Todd J; Veit HP
    Infect Immun; 1993 May; 61(5):1682-6. PubMed ID: 8478056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virulence factors of the swine pathogen Actinobacillus pleuropneumoniae.
    Tascón RI; Vázquez-Boland JA; Gutiérrez-Martín CB; Rodríguez-Barbosa JI; Rodríguez-Ferri EF
    Microbiologia; 1996 Jun; 12(2):171-84. PubMed ID: 8767702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actinobacillus pleuropneumoniae infections in closed swine herds: infection patterns and serological profiles.
    Chiers K; Donné E; Van Overbeke I; Ducatelle R; Haesebrouck F
    Vet Microbiol; 2002 Apr; 85(4):343-52. PubMed ID: 11856584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes--evaluation of isolates from lungs and tonsils of pigs.
    Gram T; Ahrens P; Andreasen M; Nielsen JP
    Vet Microbiol; 2000 Jul; 75(1):43-57. PubMed ID: 10865151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actinobacillus pleuropneumoniae: molecular aspects of virulence and pulmonary injury.
    Bertram TA
    Can J Vet Res; 1990 Apr; 54 Suppl():S53-6. PubMed ID: 2193705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological cross-reactivity between a porcine Actinobacillus strain and Haemophilus pleuropneumoniae.
    Rosendal S; Mittal KR
    Can J Comp Med; 1985 Apr; 49(2):164-70. PubMed ID: 3926287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a capsule-deficient mutant of Actinobacillus pleuropneumoniae serotype 1.
    Rioux S; Galarneau C; Harel J; Kobisch M; Frey J; Gottschalk M; Jacques M
    Microb Pathog; 2000 May; 28(5):279-89. PubMed ID: 10799278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae.
    Appleyard GD; Furesz SE; Wilkie BN
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):221-8. PubMed ID: 12007888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of Actinobacillus pleuropneumoniae by inactivation of aroQ.
    Ingham A; Zhang Y; Prideaux C
    Vet Microbiol; 2002 Jan; 84(3):263-73. PubMed ID: 11731178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].
    Xu FZ; Shi AH; Chen XL; Yang B; Wang JL
    Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):923-7. PubMed ID: 18062275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs.
    Rioux S; Girard C; Dubreuil JD; Jacques M
    Res Vet Sci; 1998; 65(2):165-7. PubMed ID: 9839897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological characterization of breakdown peptides of the 104 kilodalton hemolysin of Actinobacillus pleuropneumoniae serotype 1.
    Devenish J; Rosendal S
    Vet Microbiol; 1991 Sep; 29(1):85-93. PubMed ID: 1949556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.
    Byrd W; Harmon BG; Kadis S
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination.
    Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R
    Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs.
    Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R
    Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of Th17 cells correlates with the presence of lung lesions in pigs chronically infected with Actinobacillus pleuropneumoniae.
    Sassu EL; Ladinig A; Talker SC; Stadler M; Knecht C; Stein H; Frömbling J; Richter B; Spergser J; Ehling-Schulz M; Graage R; Hennig-Pauka I; Gerner W
    Vet Res; 2017 Feb; 48(1):4. PubMed ID: 28166835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and partial characterization of the hemolysin (HlyII) of Actinobacillus pleuropneumoniae serotype 2.
    Frey J; Deillon JB; Gygi D; Nicolet J
    Vet Microbiol; 1991 Aug; 28(3):303-12. PubMed ID: 1897133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.